Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA panel recommends approval of Verdia

Jan. 28, 1998

BioMarin's lead enzyme replacement therapy enters clinical trials

Jan. 28, 1998

Anti-TNF strategy in MS treatment should be reconsidered

Jan. 28, 1998

Rate-independent profile of antiarrhythmic agent suggests improved therapeutic potential

Jan. 28, 1998

Positive U.S. phase II results for Thymoglobulin in preventing kidney transplant rejection

Jan. 28, 1998

BMS discloses new Taxol derivative

Jan. 28, 1998

Phenylglycine derivatives with mGluR-antagonist activity disclosed by Lilly

Jan. 28, 1998

Flavopiridol analogues as inhibitors of cyclin-dependent kinases

Jan. 28, 1998

Antitumor and antiviral distamycin derivatives from Pharmacia & Upjohn

Jan. 28, 1998

Indole endothelin antagonists prepared at Pfizer

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...